 Forced Expiratory Volume
"Forced Expiratory Volume" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity.
| Descriptor ID |
D005541
|
| MeSH Number(s) |
E01.370.386.700.660.230 G09.772.650.430
|
| Concept/Terms |
Forced Expiratory Volume- Forced Expiratory Volume
- Expiratory Volume, Forced
- Expiratory Volumes, Forced
- Forced Expiratory Volumes
- Volume, Forced Expiratory
- Volumes, Forced Expiratory
- FEVt
- Vital Capacity, Timed
- Forced Vital Capacity, Timed
- Timed Vital Capacity
- Capacities, Timed Vital
- Capacity, Timed Vital
- Timed Vital Capacities
- Vital Capacities, Timed
|
Below are MeSH descriptors whose meaning is more general than "Forced Expiratory Volume".
Below are MeSH descriptors whose meaning is more specific than "Forced Expiratory Volume".
This graph shows the total number of publications written about "Forced Expiratory Volume" by people in this website by year, and whether "Forced Expiratory Volume" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1984 | 0 | 2 | 2 | | 1985 | 0 | 1 | 1 | | 1988 | 0 | 1 | 1 | | 1989 | 0 | 2 | 2 | | 1990 | 1 | 1 | 2 | | 1991 | 0 | 1 | 1 | | 1993 | 0 | 1 | 1 | | 1994 | 0 | 1 | 1 | | 1995 | 0 | 1 | 1 | | 1996 | 0 | 2 | 2 | | 1997 | 0 | 1 | 1 | | 1998 | 0 | 2 | 2 | | 1999 | 1 | 1 | 2 | | 2001 | 0 | 3 | 3 | | 2002 | 0 | 3 | 3 | | 2003 | 0 | 3 | 3 | | 2004 | 0 | 2 | 2 | | 2005 | 0 | 1 | 1 | | 2006 | 1 | 1 | 2 | | 2007 | 0 | 2 | 2 | | 2009 | 1 | 1 | 2 | | 2010 | 3 | 2 | 5 | | 2011 | 1 | 2 | 3 | | 2012 | 0 | 1 | 1 | | 2013 | 3 | 5 | 8 | | 2014 | 2 | 2 | 4 | | 2015 | 1 | 4 | 5 | | 2016 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Forced Expiratory Volume" by people in Profiles.
-
Andrianopoulos V, Celli BR, Franssen FM, Pinto-Plata VM, Calverley PM, Vanfleteren LE, Vogiatzis I, Vestbo J, Agusti A, Bakke PS, Rennard SI, MacNee W, Tal-Singer R, Yates JC, Wouters EF, Spruit MA. Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study. Respir Med. 2016 10; 119:87-95.
-
de-Torres JP, Marín JM, Casanova C, Pinto-Plata V, Divo M, Cote C, Celli BR, Zulueta JJ. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO. Chest. 2016 Apr; 149(4):936-42.
-
Brown RH, Reynolds C, Brooker A, Talalay P, Fahey JW. Sulforaphane improves the bronchoprotective response in asthmatics through Nrf2-mediated gene pathways. Respir Res. 2015 Sep 15; 16:106.
-
Lange P, Celli B, Agustí A, Boje Jensen G, Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor P, Meek P, Owen CA, Petersen H, Pinto-Plata V, Schnohr P, Sood A, Soriano JB, Tesfaigzi Y, Vestbo J. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N Engl J Med. 2015 Jul 09; 373(2):111-22.
-
Andrianopoulos V, Wouters EF, Pinto-Plata VM, Vanfleteren LE, Bakke PS, Franssen FM, Agusti A, MacNee W, Rennard SI, Tal-Singer R, Vogiatzis I, Vestbo J, Celli BR, Spruit MA. Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study. Respir Med. 2015 Sep; 109(9):1138-46.
-
Díaz AA, Pinto-Plata V, Hernández C, Peña J, Ramos C, Díaz JC, Klaassen J, Patino CM, Saldías F, Díaz O. Emphysema and DLCO predict a clinically important difference for 6MWD decline in COPD. Respir Med. 2015 Jul; 109(7):882-9.
-
Murphy KR, Dhand R, Trudo F, Uryniak T, Aggarwal A, Eckerwall G. Therapeutic equivalence of budesonide/formoterol delivered via breath-actuated inhaler vs pMDI. Respir Med. 2015 Feb; 109(2):170-9.
-
Vasilopoulos T, Kremen WS, Grant MD, Panizzon MS, Xian H, Toomey R, Lyons MJ, Jacobson KC, Franz CE. Individual differences in cognitive ability at age 20 predict pulmonary function 35 years later. J Epidemiol Community Health. 2015 Mar; 69(3):261-5.
-
Sanchez-Salcedo P, Divo M, Casanova C, Pinto-Plata V, de-Torres JP, Cote C, Cabrera C, Zagaceta J, Rodriguez-Roisin R, Zulueta JJ, Marin JM, Celli B. Disease progression in young patients with COPD: rethinking the Fletcher and Peto model. Eur Respir J. 2014 Aug; 44(2):324-31.
-
Petersen H, Sood A, Meek PM, Shen X, Cheng Y, Belinsky SA, Owen CA, Washko G, Pinto-Plata V, Kelly E, Celli B, Tesfaigzi Y. Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use. Chest. 2014 Apr; 145(4):695-703.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|